| DataWorks Group Limited (DWG) ORDINARY FULLY PAID |
Information Technology |
$6 |
Strong BetStop Outcomes and Operational Excellence Reported
|
17 Nov 2025 8:28AM |
$0.056 |
$0.056 |
fallen by
0%
|
|
| CSL Limited (CSL) ORDINARY FULLY PAID |
Health Care |
$89,093 |
Update - Notification of buy-back - CSL
|
17 Nov 2025 8:28AM |
$181.810 |
$183.640 |
risen by
1.01%
|
|
| Zip Co Limited (ZIP) ORDINARY FULLY PAID |
Financials |
$4,229 |
Update - Notification of buy-back - ZIP
|
17 Nov 2025 8:28AM |
$3.140 |
$3.300 |
risen by
5.10%
|
|
| Noxopharm Limited (NOX) ORDINARY FULLY PAID |
Health Care |
$28 |
First dose in HERACLES clinical trial Part Two
|
17 Nov 2025 8:27AM |
$0.090 |
$0.097 |
risen by
7.78%
|
|
NOX - Price-sensitive ASX Announcement
Full Release
Key Points
- First dosing in HERACLES Part Two starts.
- SOF-SKNâ„¢ tested for autoimmune diseases.
- Trial conducted in Australia for tax benefits.
- Phase I trial evaluates safety and tolerability.
- Two cohorts receive daily doses for two weeks.
- Focus on real-world application of treatments.
- Noxopharm collaborates with Doherty Clinical Trials.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| FSA Group Limited (FSA) ORDINARY FULLY PAID |
Financials |
$161 |
Update - Notification of buy-back - FSA
|
17 Nov 2025 8:27AM |
$1.235 |
$1.290 |
risen by
4.45%
|
|
| HighCom Limited (HCL) ORDINARY FULLY PAID |
Industrials |
$27 |
HighCom Armor Business Update
|
17 Nov 2025 8:27AM |
$0.285 |
$0.265 |
fallen by
7.02%
|
|
| Brambles Limited (BXB) ORDINARY FULLY PAID |
Industrials |
$32,441 |
Update - Notification of buy-back - BXB
|
17 Nov 2025 8:27AM |
$23.660 |
$23.840 |
risen by
0.76%
|
|
| L1 Long Short Fund Limited (LSF) ORDINARY FULLY PAID |
Financials |
$2,313 |
Net Tangible Asset Backing
|
17 Nov 2025 8:27AM |
$3.580 |
$3.660 |
risen by
2.23%
|
|
| Ophir High Conviction Fund (OPH) ORDINARY UNITS FULLY PAID |
Financials |
$712 |
Weekly NTA 14.11.2025
|
17 Nov 2025 8:26AM |
$3.250 |
$3.200 |
fallen by
1.54%
|
|
| Red Metal Limited (RDM) ORDINARY FULLY PAID |
Materials |
$48 |
Sybella REO Breakthrough Results From Ion Exchange Trials
|
17 Nov 2025 8:26AM |
$0.125 |
$0.128 |
risen by
2%
|
|
RDM - Price-sensitive ASX Announcement
Full Release
Key Points
- Red Metal Limited reported successful Ion Exchange trials at Sybella Rare Earth Project.
- The trials successfully separated rare earth elements (REE) from impurities such as iron and aluminium.
- A final Strip Liquor with very low impurities and a 9x enrichment of total rare earth oxide (TREO) content was achieved.
- The Ion Exchange process simplifies the flowsheet, potentially reducing capital and operating costs.
- The process increases REE recovery from Pregnant Leach Liquor to mixed rare earth carbonate (MREC) from approximately 93% to 99%.
- The simplified process offers reduced flowsheet complexity and lower alkali costs.
- Advanced comminution studies and weak-acid column heap leach tests are near completion.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| TerraCom Limited (TER) ORDINARY FULLY PAID |
Energy |
$67 |
Expected Coal Shipment Delays
|
17 Nov 2025 8:26AM |
$0.086 |
$0.084 |
fallen by
2.33%
|
|
TER - Price-sensitive ASX Announcement
Full Release
Key Points
- TerraCom Limited anticipates coal shipment delays for the December 2025 quarter due to rail and supply chain constraints.
- The Blair Athol Mine remains fully operational but logistics constraints might increase supply chain costs.
- Two shipments have already sailed, but significant coal stocks remain on-site and at the port.
- Reduced logistics availability is expected to lead to lower coal shipments and revenues for the quarter.
- The company is implementing initiatives to manage liquidity, such as prepayment arrangements and working capital funding options.
- TerraCom assures stakeholders that operational performance and market outlook remain strong.
- The situation is being closely monitored within TerraCom’s cashflow and liquidity management framework.
- The announcement was approved by the TerraCom Board for release.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Australian Clinical Labs Limited (ACL) ORDINARY FULLY PAID |
Health Care |
$565 |
Update - Notification of buy-back - ACL
|
17 Nov 2025 8:26AM |
$2.700 |
$2.890 |
risen by
7.04%
|
|
| Genetic Signatures Limited (GSS) ORDINARY FULLY PAID |
Health Care |
$62 |
2025 Annual General Meeting Chair Address & Presentation
|
17 Nov 2025 8:26AM |
$0.290 |
$0.275 |
fallen by
5.17%
|
|
GSS - Price-sensitive ASX Announcement
Full Release
Key Points
- Significant transformation and strategic realignment in FY2025.
- 66% increase in FY25 revenue with strong sales performance.
- Strategic focus on core products and U.S. market expansion.
- Leadership changes with new Directors and CEO appointment.
- Voting on resolutions including director re-elections and remuneration report.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Orora Limited (ORA) ORDINARY FULLY PAID |
Materials |
$2,791 |
Update - Notification of buy-back - ORA
|
17 Nov 2025 8:26AM |
$2.260 |
$2.240 |
fallen by
0.88%
|
|
| Genetic Signatures Limited (GSS) ORDINARY FULLY PAID |
Health Care |
$62 |
$4.4m R&D Tax Incentive Received
|
17 Nov 2025 8:26AM |
$0.290 |
$0.275 |
fallen by
5.17%
|
|
GSS - Price-sensitive ASX Announcement
Full Release
Key Points
- Genetic Signatures Limited received a $4.4 million R&D Tax Incentive refund.
- The refund was provided by the Australian Taxation Office.
- The incentive is part of the Australian Government's R&D tax program.
- The refund relates to eligible R&D activities conducted in the financial year ended 30 June 2025.
- Genetic Signatures Limited is a molecular diagnostics company focusing on infectious disease detection.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Lincoln Minerals Limited (LML) ORDINARY FULLY PAID |
Materials |
$23 |
Notification regarding unquoted securities - LML
|
17 Nov 2025 8:26AM |
$0.010 |
$0.009 |
fallen by
10%
|
|
| Light & Wonder Inc. (LNW) CHESS DEPOSITARY INTERESTS 1:1 |
Consumer Discretionary |
$12,264 |
LNW - Form 3 (Ownership Update - Fine Capital)
|
17 Nov 2025 8:26AM |
$131.660 |
$152.840 |
risen by
16.09%
|
|
| Dyno Nobel Limited (DNL) ORDINARY FULLY PAID |
Materials |
$5,925 |
Update - Notification of buy-back - DNL
|
17 Nov 2025 8:25AM |
$3.400 |
$3.300 |
fallen by
2.94%
|
|
| Light & Wonder Inc. (LNW) CHESS DEPOSITARY INTERESTS 1:1 |
Consumer Discretionary |
$12,264 |
LNW - Form 8-K (Change in Bylaws)
|
17 Nov 2025 8:25AM |
$131.660 |
$152.840 |
risen by
16.09%
|
|
| Bioxyne Limited (BXN) ORDINARY FULLY PAID |
Consumer Staple |
$81 |
Funding from SOSE to Establish UK GMP Manufacturing Facility
|
17 Nov 2025 8:25AM |
$0.039 |
$0.037 |
fallen by
5.13%
|
|
BXN - Price-sensitive ASX Announcement
Full Release
Key Points
- Bioxyne Limited expands with UK GMP manufacturing site.
- Received £850,000 funding from South of Scotland Enterprise.
- Funding includes a £500,000 loan and a £348,250 grant.
- UK facility located in Scottish Borders aimed at medicinal cannabis market.
- Licenses application planned for completion by 2026.
- UK is Europe's second-largest medicinal cannabis market.
- BLSUK seeks to replicate Australian success internationally.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Light & Wonder Inc. (LNW) CHESS DEPOSITARY INTERESTS 1:1 |
Consumer Discretionary |
$12,264 |
LNW - SC 13G-A (Ownership Update - Caledonia)
|
17 Nov 2025 8:25AM |
$131.660 |
$152.840 |
risen by
16.09%
|
|
| Latitude Group Holdings Limited (LFS) ORDINARY FULLY PAID |
Financials |
$1,175 |
Update - Notification of buy-back - LFSPA
|
17 Nov 2025 8:25AM |
$1.130 |
$1.130 |
fallen by
0%
|
|
| Electro Optic Systems Holdings Limited (EOS) ORDINARY FULLY PAID |
Industrials |
$878 |
NEW SLINGER COUNTER-DRONE ORDER (A$20M) AND BACKLOG UPDATE
|
17 Nov 2025 8:25AM |
$4.780 |
$4.550 |
fallen by
4.81%
|
|
EOS - Price-sensitive ASX Announcement
Full Release
Key Points
- New order for Slinger Counter-Drone Remote Weapon Systems worth approximately A$20 million.
- Order from a Western European NATO country with delivery expected within six months.
- Contract backlog exceeds A$400 million, with most revenue expected in 2026 and 2027.
- EOS continues to pursue additional sales opportunities.
- Order includes weapon systems, spare parts, training, and other items.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| First Au Limited (FAU) ORDINARY FULLY PAID |
Materials |
$21 |
4000m of drilling complete at Gimlet High-Grade Gold Project
|
17 Nov 2025 8:25AM |
$0.007 |
$0.008 |
risen by
14.29%
|
|
FAU - Price-sensitive ASX Announcement
Full Release
Key Points
- >4,000m of RC drilling completed at Gimlet
- Drilling aimed at upgrading resource classification from Inferred to Indicated
- Samples collected and ready for lab submission, with expedited assays
- Results will inform a refreshed Resource Estimate and may support mining studies
- Initial observations suggest gold mineralisation as per existing models
- Scout drilling conducted for exploratory purposes
- All drilling was conducted on a drill-for-equity basis by Newcam Minerals
- Previously unknown pegmatites were intersected
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Ausquest Limited (AQD) ORDINARY FULLY PAID |
Materials |
$84 |
Additional Magnetite at Morrisey
|
17 Nov 2025 8:25AM |
$0.044 |
$0.060 |
risen by
36.36%
|
|
AQD - Price-sensitive ASX Announcement
Full Release
Key Points
- Premium iron product (>70% Fe) produced at Morrisey Project.
- Three additional prospects identified for high-grade magnetite.
- Davis Tube Recoveries often exceed 30%.
- Project located near Mullewa with access to Port of Geraldton.
- Part of AusQuest's strategic initiatives under Strategic Alliance Agreement.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.